MSCA @DRUGtrain_ITN PhD Student @UU_University, @ProfArtursson's lab, working on pharmaceutical profiling of repurposing candidates for ADPKD treatment
What an exceptional 5th DRUGtrain consortium meeting! It was inspiring to witness how each individual project contributes to our collective mission of utilizing drug repurposing for the treatment of ADPKD. Lots of thanks to the University of Konstanz for hosting!
#ADPKD#MSCA
Countdown #ScienceIsWonderful in Brussels on 16-17 March 2023! ESRs @ShannonAJenkins and @_Alina_Meyer will be sharing our research on drug repurposing for treatment of ADPKD with pupils from Belgium and beyond. Visit out stand. For registrations https://t.co/yrddK8wYA4
Meet @_Alina_Meyer, PhD student at @UU_University, who within the European @DrugTrain_ITN consortium is exploring #drug#repurposing to find a treatment for the currently incurable kidney disease #ADPKD 👉 https://t.co/NpeBdPzUU2
Yesterday brought to an end the 3rd @DrugTrain_ITN consortium meeting in Aachen @RWTH where we attended a fantastic training course and had the opportunity to present our research to-date. Thanks to @twan_lammers and @k_vedangi for hosting such a great event! #DRUGtrain#ITN
Glad to be participating in our @DrugTrain_ITN consortium meeting. Looking forward to hearing all the impressive progress my colleagues are making in their research, share my progress, and have many in-person great discussions.
Outstanding educational lectures by Juergen Floege, @LaBOORatory, @rkramann and Bart Metselaar at the @DrugTrain_ITN consortium meeting in Aachen, covering the pathophysiology and pharmacotherapy of kidney disease
Inspiring and entertaining @DrugTrain_ITN Marie Curie Innovative Training Network meeting on Drug Repurposing 🧑🔬 at @RWTH Aachen. Elevator pitches by our ESR's were brilliant. Congrats @k_vedangi for winning the pitch award🏆. Thanks Babs for excellent project management🙏
8 beneficiaries across EU will join forces to train a next generation of multi-disciplinary researchers in biomedical and (bio)pharmaceutical sciences, offering a timely paradigm to improve drug repurposing with a focus on ADPKD. Follow us here: https://t.co/BW2mopFew3